...
首页> 外文期刊>British Journal of Pharmacology >Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts
【24h】

Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts

机译:3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂对缺血性犬心脏线粒体呼吸的影响

获取原文
获取原文并翻译 | 示例
           

摘要

1. Effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, pravastatin and simvastatin, on the myocardial level of coenzyme Q_(10), and on mitochrondrial respiration were examined in dogs. 2. Either vehicle (control), pravastatin (4 mg kg~(-1)day~(-1)), or simvastatin (2 mg kg~(-1)day~(-1)) was administered orally for 3 weeks. First, the myocardial tissue level of coenzyme Q_(10) was determined in the 3 groups. Second, ischaemia was induced by ligating the left anterior descending coronary artery (LAD) in anaesthetized open chest dogs, pretreated with the inhibitors. After 30 min of ischaemia, nonischaemic and ischaemic myocardium were removed from the left circumflex and LAD regions, respectively, and immediately used for isolation of mitochondria. The mitochondrial respiration was determined by polarography, with glutamate and succinate used as substrates. 3. Simvastatin significantly decreased the myocardial level of coenzyme Q_(10), but pravastatin did not. 4. Ischaemia decreased the mitochondrial respiratory control index (RCI) in both groups. Significant differences in RCI between nonischaemic and ischaemic myocardium were observed in the control and simvastatin-treated groups. 5. Only in the simvastatin-treated group did ischaemia significantly decrease the ADP/O ratio, determined with succinate. 6. The present results indicate that simvastatin but not pravastatin may cause worsening of the myocardial mitochondrial respiration during ischaemia, probably because of reduction of the myocardial coenzyme Q_(10) level.
机译:1.检查了狗中3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂普伐他汀和辛伐他汀对心肌中辅酶Q_(10)水平的影响以及对线粒体呼吸的影响。 2.口服给予媒介物(对照),普伐他汀(4 mg kg〜(-1)day〜(-1))或辛伐他汀(2 mg kg〜(-1)day〜(-1))3周。 。首先,确定3组的心肌组织中辅酶Q_(10)的水平。第二,通过在麻醉的开胸犬中结扎左前降支冠状动脉(LAD)诱导缺血,该犬经抑制剂预处理。缺血30分钟后,分别从左回旋支和LAD区域取出非缺血性和缺血性心肌,并立即用于线粒体分离。通过极谱法测定线粒体呼吸,以谷氨酸和琥珀酸酯为底物。 3.辛伐他汀能显着降低心肌辅酶Q_(10)的水平,但普伐他汀却没有。 4.缺血降低了两组的线粒体呼吸控制指数(RCI)。在对照组和辛伐他汀治疗组中,非缺血性心肌和缺血性心肌之间的RCI有显着差异。 5.仅在辛伐他汀治疗组中,缺血才能使琥珀酸盐测定的ADP / O比值显着降低。 6.目前的结果表明,辛伐他汀而不是普伐他汀可能会导致缺血期间心肌线粒体呼吸的恶化,这可能是由于心肌辅酶Q_(10)水平降低所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号